Search for Clinical Trial Results

Sponsored By

Gray Zone Lymphoma - 7 Studies Found

Status Study
Completed Study Name: Mediastinal Grey Zone Lymphoma From the LYSA
Condition: Mediastinal Grey Zone Lymphoma
Date: 2016-11-04
Recruiting Study Name: A Phase I/II Study Of Brentuximab Vedotin In Combination With Multi-Agent Chemotherapy As Front-Line Treatment In Patients With CD30 Positive Primary Mediastinal Large B-Cell, Diffuse Large B-Cell, And Grey Zone Lymphomas
Condition: CD30 Positive Primary Mediastinal Large B-cell Lymphoma, CD30 Positive Diffuse Large B-cell Lymphoma or CD30 Positive Grey Zone Lymphoma
Date: 2013-11-20
Interventions: Drug: brentuximab vedotin
Recruiting Study Name: Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma
Condition:
  • CD20+, B-cell Lymphomas
  • Mantle Cell Lymphoma
  • Non-Mantle Ce
    Date: 2012-07-27
    Interventions: Drug: Everolimus and Rituximab Everolimus: The initial dose of everolimus will be 2.5mg orally daily for
Recruiting Study Name: Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Condition:
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Primary Mediastinal Large B-cell Lymphoma
  • Date: 1999-11-03
    Interventions:
    • Drug: EPOCH Combination chemot
Withdrawn Study Name: Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Condition:
  • Diffuse Large B Cell Lymphoma
  • Mediastinal Large B-cell Lymphoma
  • Drug: Brentuximab Brentuximab

Recruiting Study Name: Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma
Condition:
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Burkit
    Date: 2013-09-12
    Interventions: Drug: CPX-351 Comparison of Different doses of drug
Recruiting Study Name: Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
Condition:
  • Acute Lymphoblastic Leukemia
  • Acute Myelogenous Leukemia
  • My
    Date: 2016-12-01
    Interventions:
    • Drug: Bendamustine